Financial Performance - The company's revenue for Q3 2022 was ¥156,234,683.85, representing a decrease of 2.60% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was ¥14,739,193.84, down 36.78% year-on-year[5] - The basic earnings per share for Q3 2022 was ¥0.1456, a decline of 62.53% compared to the previous year[5] - The company reported a decrease in net profit excluding non-recurring items to ¥14,685,131.79, a decline of 20.49% compared to the same period last year[5] - Total revenue for the third quarter was CNY 405,275,427.69, a decrease of 22.4% compared to CNY 522,331,290.35 in the same period last year[25] - Net profit for Q3 2022 was CNY 59,928,669.32, a slight decrease from CNY 60,254,430.28 in Q3 2021, representing a decline of approximately 0.54%[27] - The company reported a net profit margin of approximately 15.8% for the quarter, reflecting improved cost management[25] Assets and Equity - Total assets as of September 30, 2022, reached ¥1,121,803,581.88, an increase of 92.61% from the end of the previous year[5] - Shareholders' equity attributable to the parent company was ¥1,033,018,593.63, up 116.94% from the previous year-end[5] - The company's total assets reached CNY 1,121,803,581.88, a significant increase from CNY 582,408,612.31, marking a growth of 92.5%[24] - The capital reserve increased to CNY 613,225,202.90 from CNY 160,145,004.79, reflecting a growth of 283.5%[24] Cash Flow and Operating Activities - The cash flow from operating activities showed a net outflow of ¥12,882,424.11, a decrease of 7.00% year-to-date[5] - The company reported a net cash flow from operating activities of CNY -12,882,424.11 for Q3 2022, compared to CNY -13,852,053.36 in the same period last year, indicating a slight improvement[31] - Cash and cash equivalents increased significantly to CNY 406,837,991.49 from CNY 212,889,177.67, representing an increase of 91.1%[22] - Cash and cash equivalents at the end of Q3 2022 increased to CNY 406,837,991.49, up from CNY 83,374,003.05 at the end of Q3 2021, showing a significant increase[32] Expenses and Liabilities - R&D expenses rose by 30.22% to ¥6,258,525.97, reflecting the company's increased investment in independent product development[16] - Financial expenses skyrocketed by 806.65% to ¥7,400,842.23, mainly due to increased foreign exchange losses[16] - Other current liabilities rose by 199.25% to ¥13,934,042.00, primarily due to increased intermediary issuance fees[13] - The company experienced a 73.29% decrease in taxes and surcharges to ¥344,114.97, linked to reduced revenue due to the impact of the pandemic[16] - The company reported a tax expense of CNY 13,280,111.52 for Q3 2022, down from CNY 15,726,010.06 in Q3 2021, indicating a decrease of approximately 15.5%[27] Investments and Growth - The company plans to expand its market presence and invest in new technologies to drive future growth[25] - The company received government subsidies amounting to ¥72,551.99 in Q3 2022, primarily related to R&D and employment stabilization[8] - The company reported a significant increase in capital reserves by 282.92% to ¥613,225,202.90, resulting from the completion of the IPO[13] - The company experienced a significant increase in cash outflow from investment activities, totaling CNY 530,624,034.70 in Q3 2022, compared to CNY 407,517,555.43 in Q3 2021[32] Shareholder Information - The number of ordinary shareholders reached 15,975, with the top ten shareholders holding a combined 75.08% of the shares[18]
润贝航科(001316) - 2022 Q3 - 季度财报